Zentalis Pharmaceuticals Adds New Executives as Efforts Around Azenosertib Sharpen
The clinical-stage biopharmaceutical company named Julie Eastland as chief executive officer, president and director. She succeeds Kimberly Blackwell, who will remain as a strategic advisor to the ...